Association of Anti–Factor Xa–Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma
Author(s) -
Charles A. Karcutskie,
Arjuna Dharmaraja,
Jaimin Patel,
Sarah A. Eidelson,
Anish B. Padiadpu,
Arch G. Martin,
Gabriel Lama,
Edward B. Lineen,
Nicholas Namias,
Carl I. Schulman,
Kenneth G. Proctor
Publication year - 2017
Publication title -
jama surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.757
H-Index - 176
eISSN - 2168-6262
pISSN - 2168-6254
DOI - 10.1001/jamasurg.2017.3787
Subject(s) - medicine , dosing , enoxaparin sodium , retrospective cohort study , intensive care unit , anesthesia , population , venous thrombosis , venous thromboembolism , low molecular weight heparin , heparin , thrombosis , surgery , environmental health
The efficacy of anti-factor Xa (anti-Xa)-guided dosing of thromboprophylaxis after trauma remains controversial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom